These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1155036)

  • 21. Epidemiology of monosymptomatic optic neuritis in Rijeka County, Croatia: meteorological aspects.
    Loncarek K; Brajac I; Petricek I; Stalekar H; Cerovski B; Pokupe R
    Coll Antropol; 2005 Jun; 29(1):309-13. PubMed ID: 16117341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mtDNA haplogroup J: a contributing factor of optic neuritis.
    Reynier P; Penisson-Besnier I; Moreau C; Savagner F; Vielle B; Emile J; Dubas F; Malthièry Y
    Eur J Hum Genet; 1999 Apr; 7(3):404-6. PubMed ID: 10234520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optic neuritis: a population-based study in Olmsted County, Minnesota.
    Rodriguez M; Siva A; Cross SA; O'Brien PC; Kurland LT
    Neurology; 1995 Feb; 45(2):244-50. PubMed ID: 7854520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
    Bonhomme GR; Waldman AT; Balcer LJ; Daniels AB; Tennekoon GI; Forman S; Galetta SL; Liu GT
    Neurology; 2009 Mar; 72(10):881-5. PubMed ID: 19273821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optic neuritis in German children: clinical findings and association with multiple sclerosis.
    Tonagel F; Wilhelm H; Kelbsch C
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1523-1526. PubMed ID: 32274587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
    Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
    Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
    Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
    Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual outcome following optic neuritis: a 5-year review.
    Pedro-Egbe CN; Fiebai B; Ejimadu CS
    Niger J Clin Pract; 2012; 15(3):311-4. PubMed ID: 22960967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long-term prospective study of optic neuritis: evaluation of risk factors.
    Sandberg-Wollheim M; Bynke H; Cronqvist S; Holtås S; Platz P; Ryder LP
    Ann Neurol; 1990 Apr; 27(4):386-93. PubMed ID: 2353793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of multiple sclerosis in Finland: increase of prevalence and stability of foci in high-risk areas.
    Kinnunen E; Wikström J; Porras J; Palo J
    Acta Neurol Scand; 1983 May; 67(5):255-62. PubMed ID: 6880604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optic neuritis in Singapore.
    Lim SA; Goh KY; Tow S; Fu E; Wong TY; Seah A; Tan C; Cullen JF
    Singapore Med J; 2008 Sep; 49(9):667-71. PubMed ID: 18830538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinico-immunogenetic method of prognosis in retrobulbar neuritis as an initial manifestation of multiple sclerosis].
    Prokof'ev VF; Gribacheva IA; Konenkov VI; Ierusalimskiĭ AP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(11):43-7. PubMed ID: 1963979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the clustering of multiple sclerosis in Finland II: microepidemiology in one high-risk county with special reference to familial cases.
    Wikström J
    Acta Neurol Scand; 1975 Mar; 51(3):173-83. PubMed ID: 1146497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for developing multiple sclerosis after childhood optic neuritis.
    Lucchinetti CF; Kiers L; O'Duffy A; Gomez MR; Cross S; Leavitt JA; O'Brien P; Rodriguez M
    Neurology; 1997 Nov; 49(5):1413-8. PubMed ID: 9371931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
    Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
    Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
    Martínez-Lapiscina EH; Fraga-Pumar E; Pastor X; Gómez M; Conesa A; Lozano-Rubí R; Sánchez-Dalmau B; Alonso A; Villoslada P
    J Neurol; 2014 Apr; 261(4):759-67. PubMed ID: 24532201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing prevalence of multiple sclerosis in Finland.
    Sumelahti ML; Tienari PJ; Wikström J; Palo J; Hakama M
    Acta Neurol Scand; 2001 Mar; 103(3):153-8. PubMed ID: 11240562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.
    Optic Neuritis Study Group
    Neurology; 1997 Nov; 49(5):1404-13. PubMed ID: 9371930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of optic neuritis in Stockholm, Sweden, 1990-1995: II. Time and space patterns.
    Jin YP; de Pedro-Cuesta J; Söderström M; Link H
    Arch Neurol; 1999 Aug; 56(8):975-80. PubMed ID: 10448803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors likely to affect the development of multiple sclerosis in patients presenting with optic neuritis in a tropical and subtropical area.
    Landy PJ; Innis M; Boyle R
    Clin Exp Neurol; 1979; 16():175-82. PubMed ID: 550939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.